ASPARTATE AMINOTRANSFERASE ACC. TO IFCC WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
Received Dec 30, 2024 · Event occurred Dec 9, 2024
Report 1823260-2024-03844 · MDR key 21038996
Device
Generic name
Nadh Oxidation/nad Reduction, Ast/sgot
Manufacturer
Roche DiagnosticsCatalog number
20764949322
Lot number
80294301
Product problems
- High Test Results
- High Test Results
Patient
NA · Unknown
- No Clinical Signs, Symptoms or Conditions
- No Clinical Signs, Symptoms or Conditions
Narrative
Additional Manufacturer Narrative
CALIBRATION AND CONTROL DATA WERE ACCEPTABLE. A GENERAL REAGENT ISSUE CAN BE EXCLUDED. UPON REVIEW OF THE ALARM TRACE FOR 09-DEC-2024, 12 SAMPLE FOAM DETECTION ALARMS AND ONE SAMPLE CLOT DETECTION ALARM WERE OBSERVED. THE INVESTIGATION COULD NOT IDENTIFY A PRODUCT PROBLEM. THE ISSUE IS CONSISTENT WITH INSUFFICIENT PRE-ANALYTIC SAMPLE HANDLING.
Additional Manufacturer Narrative
THE SERIAL NUMBER OF THE C 502 ANALYZER IS (B)(6). THE INVESTIGATION IS ONGOING.
Description of Event or Problem
THE INITIAL REPORTER STATED THEY RECEIVED DISCREPANT RESULTS FOR ONE PATIENT SAMPLE TESTED WITH ASPARTATE AMINOTRANSFERASE ACC. TO IFCC WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION (AST) ON A COBAS 8000 C 502 MODULE. THE SAMPLE INITIALLY RESULTED IN AN AST VALUE OF 93.9 U/L. THE PATIENT QUESTIONED THE RESULT, SO THE SAMPLE WAS REPEATED. THE SAMPLE WAS REPEATED ON (B)(6) 2024, RESULTING IN AN AST VALUE OF 20.6 U/L. A SECOND TUBE COLLECTED AT THE SAME TIME WAS ALSO REPEATED ON A SECOND ANALYZER ON (B)(6) 2024, RESULTING IN A VALUE OF 19.9 U/L.